|
 |
| home > ebr > spring 2003 > assessing the safety of inhaled biopharmaceuticals - current issues and recent developments |
|
|
 PUBLICATIONS |
European BioPharmaceutical Review
|
It has long been recognised that inhalation is a very efficient means of introducing foreign substances into the body. As long as 500 years ago, Leonardo da Vinci realised that inhaled dust could cause lung pathology and so annotated one of his anatomical drawings of lungs - in his characteristic mirror writing - "polvere fa danno" or "dust causes damage".
The importance of inhalation as a route of exposure to injurious substances has long been recognised. For example ...
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
FT Global Pharmaceutical and Biotechnology Conference 2008
2-3 December 2008, The Cumberland, London
FT Global Pharmaceutical and Biotechnology Conference is Europe’s pre-eminent industry event attended by leading executives, government decision makers, investors, analysts and other specialist providers. It provides a unique platform to present new perspectives,’ feel the pulse’ of the industry, and network with peers across the sector.
More info >> |
|
 |
News and Press Releases |
 |
Stora Enso with DDSi is Winner of HCPC-Europe Packaging Award 2008
11th November 2008
More info >> |
|
|
